What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.44%Below 5Y avg (2.50%)
Annual Rate
CNY 0.02Paid annual
Payout Ratio
166.7%High
Last Ex-Dividend
Jul 13, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.80BCNY
1.61B · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
2.11BCNY
314.91M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-8.15%
Updated Sep 21, 2026
Beta
0.1650x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-23.58%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
10.80BCNY
1.61B · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
13.63BCNY
2.04B · vs all stocks (USD)
Updated Sep 21, 2026
Price to Sales (TTM)
5.08x
Updated Sep 21, 2026
Price to Book (MRQ)
1.16x
Updated Sep 21, 2026
Enterprise to Revenue
6.46x
Updated Sep 21, 2026
Enterprise to EBITDA
36.62x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 48.1×.Updated Sep 21, 2026
Gross Margin
22.44%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 14.21%.Updated Sep 21, 2026
Profit Margin
-8.15%
Updated Sep 21, 2026
Operating Margin
-8.90%
Updated Sep 21, 2026
Return on Assets (TTM)
-0.29%
Updated Sep 21, 2026
Return on Equity (TTM)
-1.45%
Updated Sep 21, 2026
Revenue (TTM)
2.11BCNY
314.91M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
0.8980CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
-7.40%
Updated Sep 21, 2026
Gross Profit (TTM)
299.59MCNY
44.74M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
283.39MCNY
42.32M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-171.97MCNY
-25.68M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-2.37%
Updated Sep 21, 2026
Operating Cash Flow (TTM)
1.30BCNY
194.26M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
1.07BCNY
160.43M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing Annual Dividend Rate
0.0200CNYUpdated Sep 21, 2026
Trailing Annual Dividend Yield
0.44%
vs all stocks
Updated Sep 21, 2026
5-Year Average Dividend Yield
2.50%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
166.67%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -28.57%.Updated Sep 21, 2026
Minority Interest (Equity)
517.70MCNYFY2025 · Dec 31, 2025
Revenue
2.23BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.73BCNYFY2025 · Dec 31, 2025
Gross Profit
494.12MCNYFY2025 · Dec 31, 2025
Operating Income
134.83MCNY
20.13M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
161.75MCNYFY2025 · Dec 31, 2025
Income Tax Expense
63.44MCNYFY2025 · Dec 31, 2025
Net Income
98.31MCNYFY2025 · Dec 31, 2025
EBIT
323.91MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
853.47MCNYFY2025 · Dec 31, 2025
Research & Development
45.35MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
97.85MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
34.43MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
21.28MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
162.16MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.41BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.41BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
98.31MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-25.91MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
614.57MCNYFY2025 · Dec 31, 2025
Free Cash Flow
223.20MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.78BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
98.31MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
196.95MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
384.34MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-65.03MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-391.37MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.15BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.47BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-67.75MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
4.71BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.20BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-258.18MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-156.26MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-901.26MCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.36BSharesUpdated Sep 21, 2026
Float Shares
1.71BSharesUpdated Sep 21, 2026
% Held by Insiders
32.84%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
0.40%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
3.35BCNY
500.49M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
1.42CNYUpdated Sep 21, 2026
Total Debt (MRQ)
5.91BCNY
881.96M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.5982x
Updated Sep 21, 2026
Current Ratio (MRQ)
2.03x
Updated Sep 21, 2026
Book Value per Share (MRQ)
3.89CNYUpdated Sep 21, 2026
Total Assets
19.04BCNY
2.84B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.05BCNYFY2025 · Dec 31, 2025
Total Liabilities
8.62BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
9.98BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.15BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
4.47BCNYFY2025 · Dec 31, 2025
Cash
1.64BCNYFY2025 · Dec 31, 2025
Cash Equivalents
148.88MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.79BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.82BCNYFY2025 · Dec 31, 2025
Accounts Receivable
279.57MCNYFY2025 · Dec 31, 2025
Inventory
3.18BCNYFY2025 · Dec 31, 2025
Accounts Payable
349.65MCNYFY2025 · Dec 31, 2025
Short-term Debt
2.48BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
271.47MCNYFY2025 · Dec 31, 2025
Long-term Debt
3.69BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.36BCNYFY2025 · Dec 31, 2025
Retained Earnings
6.13BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
10.41BCNY
1.56B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
52.01MCNYFY2025 · Dec 31, 2025
52-Week Low
3.50CNYUpdated Sep 21, 2026
52-Week High
6.60CNYUpdated Sep 21, 2026
52-Week Change
-23.58%
vs all stocks
Updated Sep 21, 2026
Beta
0.1650x
vs all stocks
Updated Sep 21, 2026
50-Day MA
4.47CNYUpdated Sep 21, 2026
200-Day MA
4.92CNYUpdated Sep 21, 2026
Avg 10-Day Volume
76.65MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
110.98MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.0700CNYUpdated Sep 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.66: grey zoneSignificant
Altman Z-Score: 1.66
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.61B, above the global median of $1.18BNotable
Market cap (USD): 1,613,367,515.403Global Median: 1,180,223,658.953
Levered free cash flow is $160.43M, above the global median of $18.73MNotable
Close Below 40W SMA With ProfitabilityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing
Close Below 40W SMA With ProfitabilityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing
Close Below 40W SMA With ProfitabilityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing